Gold Standard/Elsevier Launches Clinical Pharmacology Mobile
Poster: SySAdmin
Posted on March 1, 2010 at 10:58:46 AM
Gold Standard/Elsevier Launches Clinical Pharmacology Mobile
TAMPA, Florida, March 1, 2010--
- Reference Tool Puts Real-Time, Evidence-Based Drug Information
Onto Mobile Devices at the Point of Care
- Test Drive Clinical Pharmacology Mobile at HIMSS10
Gold Standard/Elsevier (http://www.goldstandard.com), a
leading provider of drug decision support announced today the availability of
Clinical Pharmacology Mobile, a mobile device-optimized web site offering
users access to the features and functions of Clinical Pharmacology, an
award-winning electronic drug information and medication management
reference. Experience Clinical Pharmacology Mobile at the HIMSS (Healthcare
Information Management Systems Society) annual meeting, March 1-4, 2010, in
Atlanta (Elsevier's Booth #6503/6509).
(Photo:
http://www.newscom.com/cgi-bin/prnh/20100301/380799 )
"Clinical Pharmacology Mobile provides healthcare
professionals and students with reliable, need-to-know drug information when
and where they need it. We've built a mobile version looking to the future
and to our customers' emerging needs," said Kathy Vieson, PharmD, BCOP, Vice
President and Director of Clinical Drug References for Gold
Standard/Elsevier. "The release of Clinical Pharmacology Mobile reflects Gold
Standard's commitment to provide quality drug information and accurate
answers to point-of-care questions with enhanced speed, ease and
convenience."
Focused on supporting routine medication information needs,
Clinical Pharmacology Mobile allows users to search by trade or generic drug
name, indication, contraindication/precaution or adverse reaction, and to
browse by monograph or classification. Clinicians can access drug monographs,
multi-drug interaction reports, MedCounselor consumer medication information,
drug product information, drug images and clinical calculators. In addition,
users can purchase supplemental modules such as Drug IDentifier/NDC Search,
IV Compatibility information and reports via Trissel's 2 Database, Global
Drug Name Directory, FormChecker hospital formulary management and
OnFormulary health plan formularies.
The Clinical Pharmacology Mobile web site is supported on
devices that use standard browsers, such as the iPhone/iPod Touch, BlackBerry
devices, T Mobile G1 and Nokia N85, and runs on the Apple, RIM, Android,
Symbian, and Windows Mobile 6 operating systems.
"With nothing to download, no synching required and continuous
updating, Clinical Pharmacology Mobile provides users with the most timely,
accurate and reliable drug information available," says Vieson. "By adding
Clinical Pharmacology Mobile to our drug reference suite, our goal is to
ensure our customers have the content they need at every access point, be
that online, in their workflow systems and now on their mobile devices."
The number of cell phone subscriptions across the globe will
hit 5 billion sometime in 2010, precipitated in part by the demand for mobile
healthcare services, according to the International Telecommunication Union.
McKinsey & Company projects that the global mobile health opportunity could
be worth more than $60 billion, while Mobile Health Initiative founder Peter
Waegemann predicts a mobile health revolution where publishers move
scientific knowledge "from books to apps."
About Gold Standard
Based in Tampa, FL, Gold Standard/Elsevier uses innovative
technologies to provide a complete suite of drug information and decision
support solutions. With a tenacious commitment to product quality, Gold
Standard/Elsevier solutions empower healthcare organizations, professionals
and consumers to meet the most pressing healthcare challenges, improve
patient safety and ensure optimal outcomes. To learn more about Gold
Standard/Elsevier, visit http://www.goldstandard.com.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell
(http://www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com),
Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and
Nursing Consult (http://www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com),
which help research and health care institutions deliver better outcomes more
cost-effectively.
A global business headquartered in Amsterdam, Elsevier
(http://www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Tom Reller
VP, Global Corporate Relations, Elsevier
+1-215-239-3508
T.Reller@elsevier.com
Photo:
http://www.newscom.com/cgi-bin/prnh/20100301/380799
Source: Elsevier
Tom Reller, VP, Global Corporate Relations, Elsevier, +1-215-239-3508, T.Reller@elsevier.com
TAMPA, Florida, March 1, 2010--
- Reference Tool Puts Real-Time, Evidence-Based Drug Information
Onto Mobile Devices at the Point of Care
- Test Drive Clinical Pharmacology Mobile at HIMSS10
Gold Standard/Elsevier (http://www.goldstandard.com), a
leading provider of drug decision support announced today the availability of
Clinical Pharmacology Mobile, a mobile device-optimized web site offering
users access to the features and functions of Clinical Pharmacology, an
award-winning electronic drug information and medication management
reference. Experience Clinical Pharmacology Mobile at the HIMSS (Healthcare
Information Management Systems Society) annual meeting, March 1-4, 2010, in
Atlanta (Elsevier's Booth #6503/6509).
(Photo:
http://www.newscom.com/cgi-bin/prnh/20100301/380799 )
"Clinical Pharmacology Mobile provides healthcare
professionals and students with reliable, need-to-know drug information when
and where they need it. We've built a mobile version looking to the future
and to our customers' emerging needs," said Kathy Vieson, PharmD, BCOP, Vice
President and Director of Clinical Drug References for Gold
Standard/Elsevier. "The release of Clinical Pharmacology Mobile reflects Gold
Standard's commitment to provide quality drug information and accurate
answers to point-of-care questions with enhanced speed, ease and
convenience."
Focused on supporting routine medication information needs,
Clinical Pharmacology Mobile allows users to search by trade or generic drug
name, indication, contraindication/precaution or adverse reaction, and to
browse by monograph or classification. Clinicians can access drug monographs,
multi-drug interaction reports, MedCounselor consumer medication information,
drug product information, drug images and clinical calculators. In addition,
users can purchase supplemental modules such as Drug IDentifier/NDC Search,
IV Compatibility information and reports via Trissel's 2 Database, Global
Drug Name Directory, FormChecker hospital formulary management and
OnFormulary health plan formularies.
The Clinical Pharmacology Mobile web site is supported on
devices that use standard browsers, such as the iPhone/iPod Touch, BlackBerry
devices, T Mobile G1 and Nokia N85, and runs on the Apple, RIM, Android,
Symbian, and Windows Mobile 6 operating systems.
"With nothing to download, no synching required and continuous
updating, Clinical Pharmacology Mobile provides users with the most timely,
accurate and reliable drug information available," says Vieson. "By adding
Clinical Pharmacology Mobile to our drug reference suite, our goal is to
ensure our customers have the content they need at every access point, be
that online, in their workflow systems and now on their mobile devices."
The number of cell phone subscriptions across the globe will
hit 5 billion sometime in 2010, precipitated in part by the demand for mobile
healthcare services, according to the International Telecommunication Union.
McKinsey & Company projects that the global mobile health opportunity could
be worth more than $60 billion, while Mobile Health Initiative founder Peter
Waegemann predicts a mobile health revolution where publishers move
scientific knowledge "from books to apps."
About Gold Standard
Based in Tampa, FL, Gold Standard/Elsevier uses innovative
technologies to provide a complete suite of drug information and decision
support solutions. With a tenacious commitment to product quality, Gold
Standard/Elsevier solutions empower healthcare organizations, professionals
and consumers to meet the most pressing healthcare challenges, improve
patient safety and ensure optimal outcomes. To learn more about Gold
Standard/Elsevier, visit http://www.goldstandard.com.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical
and medical information products and services. The company works in
partnership with the global science and health communities to publish more
than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell
(http://www.cell.com), and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com),
Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and
Nursing Consult (http://www.nursingconsult.com), which enhance the
productivity of science and health professionals, and the SciVal suite
(http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com),
which help research and health care institutions deliver better outcomes more
cost-effectively.
A global business headquartered in Amsterdam, Elsevier
(http://www.elsevier.com) employs 7,000 people worldwide. The company is part
of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),
REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Tom Reller
VP, Global Corporate Relations, Elsevier
+1-215-239-3508
T.Reller@elsevier.com
Photo:
http://www.newscom.com/cgi-bin/prnh/20100301/380799
Source: Elsevier
Tom Reller, VP, Global Corporate Relations, Elsevier, +1-215-239-3508, T.Reller@elsevier.com